AHP will modify Orudis KT implied overall superiority claim in future ads -- NAD.
This article was originally published in The Tan Sheet
AHP ORUDIS KT "UNINTENDED" OVERALL SUPERIORITY CLAIM over other headache medicines should be eliminated in future advertising, the National Advertising Division of the Council of Better Business Bureaus said in an Aug. 29 NAD Case Report. American Home Products disagreed with NAD's decision but said that it would not appeal because the series of television commercials has been discontinued "in the ordinary course of business." The company agreed to take NAD's comments into account when developing new ads.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC